110 related articles for article (PubMed ID: 7535040)
41. [Effects of low doses of aprotinin in heart surgery].
Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J
Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188
[TBL] [Abstract][Full Text] [Related]
42. [Evaluation of the hemostatic potential at coronary artery bypass surgery during long-term aspirin therapy].
Gruzdeva OV; Fanaskova EV; Akbasheva OE; Uchasova EG; Penskaya TY; Plotnikov GP; Dyleva YA; Krivoshapova KE; Barbarash OL
Ter Arkh; 2016; 88(12):21-27. PubMed ID: 28139555
[TBL] [Abstract][Full Text] [Related]
43. Platelet function in cardiac surgery: influence of temperature and aprotinin.
Boldt J; Knothe C; Zickmann B; Bill S; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Mar; 55(3):652-8. PubMed ID: 7680852
[TBL] [Abstract][Full Text] [Related]
44. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
45. Topical aprotinin in cardiac operations.
O'Regan DJ; Giannopoulos N; Mediratta N; Kendall SW; Forni A; Pillai R; Westaby S
Ann Thorac Surg; 1994 Sep; 58(3):778-81. PubMed ID: 7524457
[TBL] [Abstract][Full Text] [Related]
46. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery.
Mössinger H; Dietrich W; Braun SL; Jochum M; Meisner H; Richter JA
Ann Thorac Surg; 2003 Feb; 75(2):430-7. PubMed ID: 12607650
[TBL] [Abstract][Full Text] [Related]
47. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
48. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass.
Carrel T; Bauer E; Laske A; von Segesser L; Turina M
Lancet; 1991 Mar; 337(8742):673. PubMed ID: 1705649
[No Abstract] [Full Text] [Related]
49. Blood conservation techniques and platelet function in cardiac surgery.
Boldt J; Zickmann B; Czeke A; Herold C; Dapper F; Hempelmann G
Anesthesiology; 1991 Sep; 75(3):426-32. PubMed ID: 1716079
[TBL] [Abstract][Full Text] [Related]
50. [Effects of "low dose" aprotinin in open heart surgery and its plasma concentration].
Nakamura T; Shimamoto M; Yamazaki F; Fujita S; Yoshimura T; Ueno T; Oyanagi H; Shinozaki T
Nihon Kyobu Geka Gakkai Zasshi; 1994 Feb; 42(2):188-93. PubMed ID: 7511150
[TBL] [Abstract][Full Text] [Related]
51. [Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery].
Corbeau JJ; Monrigal JP; Jacob JP; Cottineau C; Moreau X; Bukowski JG; Subayi JB; Delhumeau A
Ann Fr Anesth Reanim; 1995; 14(2):154-61. PubMed ID: 7486272
[TBL] [Abstract][Full Text] [Related]
52. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations.
Dietrich W; Schöpf K; Spannagl M; Jochum M; Braun SL; Meisner H
Ann Thorac Surg; 1998 Jan; 65(1):70-7; discussion 77-8. PubMed ID: 9456098
[TBL] [Abstract][Full Text] [Related]
53. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass.
Ray MJ; Marsh NA; Just SJ; Perrin EJ; O'Brien MF; Hawson GA
Ann Thorac Surg; 1997 Jan; 63(1):57-63. PubMed ID: 8993241
[TBL] [Abstract][Full Text] [Related]
54. [THE ROLE OF LOW-FREQUENCY PIEZOTHROMBOELASTOGRAPHY IN THE COMPREHENSIVE EVALUATION OF HEMOSTASIS IN CORONARY BYPASS SURGERY WITH CARDIOPULMONARY BYPASS].
Fanaskova EV; Gruzdeva OV; Akbasheva OE; Tyutrin II; Penskaya TY; Uchasova EG; Plotnikov GP; Krivoshapova KE; Barbarash OL
Klin Med (Mosk); 2017; 95(3):245-53. PubMed ID: 30303352
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
56. Invited letter concerning: topical aprotinin.
Edmunds LH
J Thorac Cardiovasc Surg; 1995 Feb; 109(2):400-2. PubMed ID: 7531800
[No Abstract] [Full Text] [Related]
57. Effects of epsilon-aminocaproic acid and aprotinin on leukocyte-platelet adhesion in patients undergoing cardiac surgery.
Greilich PE; Brouse CF; Rinder CS; Smith BR; Sandoval BA; Rinder HM; Eberhart RC; Jessen ME
Anesthesiology; 2004 Feb; 100(2):225-33. PubMed ID: 14739793
[TBL] [Abstract][Full Text] [Related]
58. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
Lemmer JH; Stanford W; Bonney SL; Breen JF; Chomka EV; Eldredge WJ; Holt WW; Karp RB; Laub GW; Lipton MJ
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):543-51; discussion 551-3. PubMed ID: 7508070
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
Huang H; Ding W; Su Z; Zhang W
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
[TBL] [Abstract][Full Text] [Related]
60. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
